Forward Air Corp (FWRD) Jumps 5.97% on February 16

Equities Staff |

Forward Air Corp (FWRD) was among the biggest gainers on the Russell 2000 for Tuesday February 16 as the stock popped 5.97% to $39.75, representing a gain of $2.24 per share. Some 213,256 shares traded hands on 2,633 trades, compared with an average daily volume of 205,606 shares out of a total float of 30.83 million. The stock opened at $37.91 and traded with an intraday range of $40.45 to $37.71.

After today's gains, Forward Air Corp reached a market cap of $1.23 billion. Forward Air Corp has had a trading range between $57.65 and $36.00 over the last year, and it had a 50-day SMA of $42.82 and a 200-day SMA of $46.77.

The stock has a P/E Ratio of 21.

Forward Air Corp provides surface transportation & logistics services to the North American deferred air freight market. Its operations are classified into three segments: Forward Air, Inc., Forward Air Solutions, Inc., & Total Quality, Inc.

Forward Air Corp is based out of Greeneville, TN and has some 3,902 employees. Its CEO is Bruce A. Campbell.

For a complete fundamental analysis analysis of Forward Air Corp, check out’s Stock Valuation Analysis report for FWRD. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets


D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing, and computer science into breakthrough approaches to computation to help solve…

Ozobot by Evollve Inc

Ozobot is a world leader in compact super intelligent robots that entertain and educate through fun interactive gaming.